Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial

Kasper Iversen, Annette S Jensen, Tim V Jensen, Niels G Vejlstrup, Lars Søndergaard, Annette Schophuus Jensen

    Research output: Contribution to journalJournal articleResearchpeer-review

    163 Citations (Scopus)

    Abstract

    To evaluate the efficacy of combining the dual endothelin receptor antagonist, bosentan, and the phosfodiesterase-5-inhibitor, sildenafil, in patients with Eisenmenger syndrome.
    Original languageEnglish
    JournalEuropean Heart Journal
    Volume31
    Issue number9
    Pages (from-to)1124-31
    Number of pages8
    ISSN0195-668X
    DOIs
    Publication statusPublished - 1 May 2010

    Cite this